<!DOCTYPE html>
<html lang="en">
    <head>
        <!-- Google tag (gtag.js) -->
        <script async src="https://www.googletagmanager.com/gtag/js?id=G-ZH82SXNCBR%22%3E"></script>
        <script>
            window.dataLayer = window.dataLayer || [];
            function gtag(){dataLayer.push(arguments);}
            gtag('js', new Date());

            gtag('config', 'G-ZH82SXNCBR');
        </script>
        <meta charset="utf-8" />
        <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no" />
        <meta name="description" content="" />
        <meta name="author" content="" />
        <title>YJSR</title>
        <link rel="icon" type="image/x-icon" href="../assets/favicon.ico" />
        <!-- Font Awesome icons (free version)-->
        <script src="https://use.fontawesome.com/releases/v5.15.4/js/all.js" crossorigin="anonymous"></script>
        <!-- Google fonts-->
        <link href="https://fonts.googleapis.com/css?family=Lora:400,700,400italic,700italic" rel="stylesheet" type="text/css" />
        <link href="https://fonts.googleapis.com/css?family=Open+Sans:300italic,400italic,600italic,700italic,800italic,400,300,600,700,800" rel="stylesheet" type="text/css" />
        <!-- Core theme CSS (includes Bootstrap)-->
        <link href="../css/styles.css" rel="stylesheet" />
        <style>
            .ref > li, .cont-list > li {
                margin: 18px 0;
            }
            .ref > li > a {
                text-decoration: underline;
            }
            .cont :hover {
                color: #0085A1;
            }
            .illus-img {
                width: 100%;
                border-radius: 9px;
            }
            .img-cap {
                font-style: italic;
                text-align: center;
                font-size: 18px;
            }
        </style>
    </head>
    <body>
        <!-- Navigation-->
        <nav class="navbar navbar-expand-lg navbar-light" id="mainNav">
            <div class="container px-4 px-lg-5">
                <a class="navbar-brand" href="../">YJSR</a>
                <button class="navbar-toggler" type="button" data-bs-toggle="collapse" data-bs-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false" aria-label="Toggle navigation">
                    Menu
                    <i class="fas fa-bars"></i>
                </button>
                <div class="collapse navbar-collapse" id="navbarResponsive">
                    <ul class="navbar-nav ms-auto py-4 py-lg-0">
                        <li class="nav-item"><a class="nav-link px-lg-3 py-3 py-lg-4" href="../">Home</a></li>
                        <li class="nav-item"><a class="nav-link px-lg-3 py-3 py-lg-4" href="../about">About</a></li>
                        <li class="nav-item"><a class="nav-link px-lg-3 py-3 py-lg-4" href="../publish">Publish</a></li>
                        <li class="nav-item"><a class="nav-link px-lg-3 py-3 py-lg-4" href="../join">Join</a></li>
                    </ul>
                </div>
            </div>
        </nav>
        <!-- Page Header-->
        <header class="masthead" style="background-image: url('https://metro.co.uk/wp-content/uploads/2023/08/GettyImages-1477214805.jpg?quality=90&strip=all&crop=0px%2C21px%2C777px%2C408px&resize=1200%2C630')">
            <div class="container position-relative px-4 px-lg-5">
                <div class="row gx-4 gx-lg-5 justify-content-center">
                    <div class="col-md-10 col-lg-8 col-xl-7">
                        <div class="post-heading">
                            <h1>AOH 1996: A Potential Cure for Cancer?</h1> 
                            <h2 class="subheading"><!-- Article Subtitle --></h2> 
                            <span class="meta">
                                Posted by 
                                <a href="">Mridul Yadav</a> <!-- Author Contact, if present in the `href` string. -->
                                on August 27, 2023
                            </span>
                        </div>
                    </div>
                </div>
            </div>
        </header>
        <!-- Post Content-->
        <article class="mb-4">
            <div class="container px-4 px-lg-5">
                <div class="row gx-4 gx-lg-5 justify-content-center">
                    <div class="col-md-10 col-lg-8 col-xl-7">
                        <!-- Main Content/ Article Body -->
                        
                        <p>Cancer is one of the leading causes of death worldwide, affecting millions of people every year. Despite the advances in diagnosis and treatment, many cancers remain incurable or resistant to conventional therapies. However, a new experimental drug, AOH 1996, may offer a ray of hope for cancer patients.</p>
                        
                        <h2 class="section-heading">What is AOH 1996?</h2>
                        <p>AOH 1996 is a small molecule that inhibits a protein called proliferating cell nuclear antigen (PCNA), which is essential for DNA replication and repair. PCNA is normally found in all cells, but it is also present in a modified form, called caPCNA, in cancer cells. CaPCNA helps cancer cells survive and proliferate under stressful conditions, such as DNA damage or chemotherapy. By targeting caPCNA, AOH 1996 aims to selectively kill cancer cells without harming normal cells.</p>
                        
                        <h2 class="section-heading">How effective is AOH 1996?</h2>
                        <p>AOH 1996 has been tested in vitro (in cell cultures) and in vivo (in animal models) and has shown promising results. <a href="https://www.news-medical.net/news/20230804/New-PCNA-inhibitor-AOH1996-shows-selective-cancer-cell-killings-and-tumor-suppression-potential.aspx">According to a recent study published in the journal Cell Chemical Biology1,</a> AOH 1996 inhibited the growth and induced cell cycle arrest and apoptosis (programmed cell death) in a wide variety of cancer cell lines, including lung, breast, prostate, colon, ovarian, and brain cancers. Moreover, AOH 1996 had no effect on several normal, non-malignant cell types, indicating its specificity and safety.<br><br>
                        In animal studies, AOH 1996 also demonstrated its anti-cancer activity and lack of toxicity. <a href="https://www.news-medical.net/news/20230804/New-PCNA-inhibitor-AOH1996-shows-selective-cancer-cell-killings-and-tumor-suppression-potential.aspx">In mice and dogs with xenograft tumors (tumors derived from human cancer cells), AOH 1996 significantly reduced tumor size and weight without causing significant weight loss or death in the animals.1</a> The drug also had a long half-life (the time it takes for half of the drug to be eliminated from the body), which means it could be administered less frequently and at lower doses.</p>
                        
                        <h2 class="section-heading">What is the status of AOH 1996?</h2>
                        <p>AOH 1996 is currently in Phase I clinical trials, which are the first stage of testing a new drug in humans. The main goal of Phase I trials is to determine the safety, dosage, and side effects of the drug in a small group of healthy volunteers or patients with advanced cancer. <a href="https://edgeservices.bing.com/edgesvc/chat?udsframed=1&form=SHORUN&clientscopes=chat,noheader,channelstable,&shellsig=5ac7c6df38b3842fccb73612fb64898c6f79ab07&setlang=en-US&lightschemeovr=1">The trial started in July 2023 and is expected to enroll up to 30 participants.2</a> The trial is sponsored by the National Cancer Institute (NCI) and conducted at several sites across the United States.</p>
                        
                        <h2 class="section-heading">What is the story behind AOH 1996?</h2>
                        <p>AOH 1996 is named after Anna Olivia Healey, a young girl who died of neuroblastoma, a rare and aggressive childhood cancer, in 2006. Her parents, John and Mary Healey, founded the Anna Olivia Healey Foundation to raise funds and awareness for neuroblastoma research. They also supported the development of AOH 1996 by donating to the laboratory of <a href="https://www.msn.com/en-us/health/medical/new-cancer-hope-as-a-pill-annihilates-all-solid-tumors-thanks-to-this-little-girl/ar-AA1eHZcv">Dr. Linda Malkas, a professor of molecular biology at City of Hope National Medical Center and one of the inventors of the drug3.</a><br><br>Dr. Malkas said she was inspired by Anna’s courage and spirit to create a drug that could help other children and adults with cancer. 
                        <a href="https://en.wikipedia.org/wiki/AOH1996">“I knew I wanted to do something special for that little girl,” she said4.</a></p>
                        
                        <h2 class="section-heading">What are the challenges and limitations of AOH 1996?</h2>
                        <p>While AOH 1996 has shown remarkable results in preclinical studies, it still faces many challenges and limitations before it can be approved as a new treatment for cancer. Some of these include:</p>
                        <ul>
                            <li>The need for more clinical trials to confirm its efficacy, safety, and optimal dosage in larger and more diverse groups of patients with different types of cancers.</li>
                            <li>The possibility of resistance or adverse reactions to the drug in some patients or over time.</li>
                            <li>The cost and availability of the drug for patients who need it.</li>
                            <li>The ethical and social implications of targeting a protein that is also involved in normal cellular functions.</li>
                        </ul>
                        
                        <h2 class="section-heading">Conclusion</h2>
                        <p>AOH 1996 is an innovative drug that targets a unique feature of cancer cells: caPCNA. It has shown remarkable potential to kill cancer cells without harming normal cells in laboratory and animal studies. It is now being tested in humans for the first time in Phase I clinical trials. If successful, it could offer a new option for treating various cancers that are currently incurable or resistant to existing therapies.<br><br>
                        However, as with any new drug, there are still many uncertainties and challenges ahead. We cannot be sure about its effectiveness or safety until more data are available from human trials. We also need to consider the ethical and social aspects of manipulating a protein that is essential for life. Therefore, while we can hope for a miracle, we also need to be realistic and cautious about AOH 1996.</p>
                        
                        <h2 class="section-heading"></h2>
                        
                        
                        <h2 class="section-heading"></h2>

                    </div>
                </div>
            </div>
        </article>
<!-- Footer-->
        <footer class="border-top">
            <div class="container px-4 px-lg-5">
                <div class="row gx-4 gx-lg-5 justify-content-center">
                    <div class="col-md-10 col-lg-8 col-xl-7">
                        <ul class="list-inline text-center">
                            <li class="list-inline-item">
                                <a href="#!">
                                    <span class="fa-stack fa-lg">
                                        <i class="fas fa-circle fa-stack-2x"></i>
                                        <i class="fab fa-reddit-alien fa-stack-1x fa-inverse"></i>
                                    </span>
                                </a>
                            </li>
                            <li class="list-inline-item">
                                <a href="https://www.instagram.com/yjsr.tech/">
                                    <span class="fa-stack fa-lg">
                                        <i class="fas fa-circle fa-stack-2x"></i>
                                        <i class="fab fa-instagram fa-stack-1x fa-inverse"></i>
                                    </span>
                                </a>
                            </li>
                            <li class="list-inline-item">
                                <a href="https://www.linkedin.com/company/youth-journal-of-stem-research">
                                    <span class="fa-stack fa-lg">
                                        <i class="fas fa-circle fa-stack-2x"></i>
                                        <i class="fab fa-linkedin fa-stack-1x fa-inverse"></i>
                                    </span>
                                </a>
                            </li>
                        </ul>
                        <div class="small text-center text-muted fst-italic">Copyright &copy; YJSR 2022</div>
                    </div>
                </div>
            </div>
        </footer>
        <!-- Bootstrap core JS-->
        <script src="https://cdn.jsdelivr.net/npm/bootstrap@5.1.3/dist/js/bootstrap.bundle.min.js"></script>
        <!-- Core theme JS-->
        <script src="js/scripts.js"></script>
    </body>
</html>